Maxion Therapeutics
Maxion Therapeutics is a startup headquartered in London, United Kingdom, founded in 2020. It has won about £1.95m in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Maxion Therapeutics has won about £1.95m in competitive Innovate UK grants since 2023.
- Development of a novel class of ion channel blockers for the treatment of autoimmune disease (£1.95m, 2023)
R&D ecosystem
Maxion Therapeutics sits inside the London and the Golden Triangle R&D ecosystem in the Global R&D Labs Directory.
Other startups in London
- Abtrace
- Adjsoft
- Aeon Energy
- Amphibio
- Anserine Labs
- APIContext
- Apoha
- AppyParking
- Archangel Lightworks
- Arda Biomaterials
- Bark
Related
- Innovation profile of London
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Maxion Therapeutics do?
Maxion Therapeutics works in deep tech research. Its Innovate UK projects include: Development of a novel class of ion channel blockers for the treatment of autoimmune disease.
Where is Maxion Therapeutics based?
Maxion Therapeutics is headquartered in London, United Kingdom.
When was Maxion Therapeutics founded?
Maxion Therapeutics was founded in 2020.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.